Granted Patent B2

US 12,543,738 · App. 18/010,736 · Granted Feb 10, 2026

Inventors: Julie Geist (Lyons, FR); Cyril Montagne (Lyons, FR); Lionel Nicolas (Lyons, FR); Tomoki Tsuchiya (Lyons, FR); Vincent Thomas (Lyons, FR); Dominique Loque (Satigny, CH)

Assignee: BAYER AKTIENGESELLSCHAFT

A01N43/88A01N43/38A01N43/58A01P3/00C07D209/48C07D237/14C07D237/24C07D403/12C07D413/04

Abstract

Claims (95)

1 . A compound selected from the group consisting of

(I-001) (5RS)-5-(2-bromo-4-methylbenzyl)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-002) (5RS)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5-(2,4-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-003) (5RS)-5-(2-chloro-4-methylbenzyl)-3-[3-(2-fluoro-3-methylphenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-004) (5RS)-5-(2-chloro-4-methylbenzyl)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-005) (5RS)-3-[6-chloro-3-(2-fluoro-3-methylphenoxy)pyridazin-4-yl]-5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-006) (5RS)-5-(2-bromo-4-methylbenzyl)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-007) (5RS)-5-(2,4-dichlorobenzyl)-3-[3-(2-fluoro-3-methylphenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-008) (5RS)-5-(3,5-dimethylbenzyl)-3-[3-(2-fluoro-3-methylphenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-009) (5RS)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5-(3,5-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-010) (5RS)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(3,5-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-011) (5RS)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5-(2,5-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-012) (5RS)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2,5-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-013) (5RS)-5-(2,5-dimethylbenzyl)-3-[3-(2-fluoro-3-methylphenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-014) (5RS)-5-(2,4-dimethylbenzyl)-3-[3-(3-ethyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-015) (5RS)-5-(2,4-dimethylbenzyl)-3-{3-[3-(1-fluorocyclopropyl)phenoxy]-6-methylpyridazin-4-yl}-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-016) 1-{6-(3-cyclopropylphenoxy)-5-[5-(2,4-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazin-3-yl]pyridazin-3-yl}ethanol;

(I-017) (5RS)-3-[6-chloro-3-(3-chlorophenoxy)pyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-018) (5RS)-3-{3-(3-cyclopropyl-2-fluorophenoxy)-6-[(1RS)-1-fluoroethyl]pyridazin-4-yl}-5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-019) (5RS)-3-[3-(3-cyclopropylphenoxy)-6-(1-ethoxyvinyl)pyridazin-4-yl]-5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-020) (5RS)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-(1-ethoxyvinyl)pyridazin-4-yl]-5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-021) (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-(dichloromethyl)pyridazin-4-yl]-5-(2,4-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-022) (5RS)-3-{3-[3-(1-chlorocyclopropyl)phenoxy]-6-methylpyridazin-4-yl}-5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-023) 1-{6-(3-cyclopropyl-2-fluorophenoxy)-5-[5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazin-3-yl]pyridazin-3-yl}ethanol;

(I-024) (5RS)-3-{6-chloro-3-[3-(1-chlorocyclopropyl)phenoxy]pyridazin-4-yl}-5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine; and

(I-025) (5RS)-3-[6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)pyridazin-4-yl]-5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine-4-carbaldehyde,

or a salt, an N-oxide, or a solvate thereof of any of the foregoing.

2 . The compound according to claim 1 ,

wherein the compound is selected from the group consisting of

(I.001) (5RS)-5-(2-bromo-4-methylbenzyl)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.002) (5RS)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5-(2,4-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I-003) (5RS)-5-(2-chloro-4-methylbenzyl)-3-[3-(2-fluoro-3-methylphenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.004) (5RS)-5-(2-chloro-4-methylbenzyl)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.005) (5RS)-3-[6-chloro-3-(2-fluoro-3-methylphenoxy)pyridazin-4-yl]-5-(2,4-dichlorobenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.006) (5RS)-5-(2-bromo-4-methylbenzyl)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.007) (5RS)-5-(2,4-dichlorobenzyl)-3-[3-(2-fluoro-3-methylphenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.008) (5RS)-5-(3,5-dimethylbenzyl)-3-[3-(2-fluoro-3-methylphenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.009) (5RS)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5-(3,5-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.010) (5RS)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(3,5-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.011) (5RS)-3-[3-(3-chlorophenoxy)-6-methylpyridazin-4-yl]-5-(2,5-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.012) (5RS)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2,5-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.013) (5RS)-5-(2,5-dimethylbenzyl)-3-[3-(2-fluoro-3-methylphenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine;

(I.014) (5RS)-5-(2,4-dimethylbenzyl)-3-[3-(3-ethyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine; and

(I.015) (5RS)-5-(2,4-dimethylbenzyl)-3-{3-[3-(1-fluorocyclopropyl)phenoxy]-6-methylpyridazin-4-yl}-5,6-dihydro-4H-1,2,4-oxadiazine.

3 . A fungicidal composition for controlling phytopathogenic harmful fungi, comprising at least one compound according to claim 1 and at least one carrier and/or surfactant.

4 . A method for controlling harmful microorganisms in crop protection and in the protection of materials, comprising applying at least one compound according to claim 1 to the harmful microorganisms and/or their habitat.

5 . A method for controlling harmful microorganisms in crop protection or in material protection, comprising applying a composition according to claim 3 to the harmful microorganisms and/or their habitat.

6 . A process for preparing a compound of formula (I-a), comprising reacting a compound of formula (1)

wherein

U 1 is hydroxy, halogen or C 1 -C 6 -alkoxy,

with an amine of formula (2)

wherein

W is hydrogen, tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl, or one of its salts to provide a compound of formula (3)

from which the phthalimide group is removed to yield a compound of formula (4)

which is then treated, when W is hydrogen, with a dehydrating agent, optionally in the presence of a base to obtain directly the compound of formula (I-a)

wherein

R 3 and R 4 are hydrogen

R 5 is hydrogen,

L is methylene,

R 6 is phenyl,

wherein phenyl is substituted with 2 substituents independently selected from chloro, bromo and methyl,

R 7 is chloro, methyl, ethyl or ethenyl,

wherein methyl, ethyl and ethenyl are optionally substituted with one or two substituents independently selected from the group consisting of fluoro, chloro, hydroxy, methoxy and ethoxy,

R 8 is hydrogen,

Q is phenyl,

wherein phenyl is substituted with one or two substituents independently selected from fluoro, chloro, methyl, ethyl and cyclopropyl,

wherein cyclopropyl is optionally substituted with one or two substituents independently selected from the group consisting of fluoro and chloro,

or

which is then treated, when W is an aminoprotecting group selected from the group consisting of tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl, with a dehydrating agent, optionally in the presence of a base, and then performing a deprotection step to obtain the compound of formula (I-a).

7 . A process for preparing a compound of formula (I-a), comprising reacting a compound of formula (5)

wherein

X is halogen,

U 1 is hydroxy, halogen or C 1 -C 6 -alkoxy,

with an amine of formula (2)

wherein

W is hydrogen, tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl, or one of its salts, to provide a compound of formula a compound of formula (6a)

wherein

G is phthalimido,

from which the phtalimide group is removed to obtain a compound of formula (6b)

which is then treated, when W is hydrogen, with a dehydrating agent, optionally in the presence of a base to obtain directly a compound of formula (7)

or

which is then treated, when W is an aminoprotecting group, with a dehydrating agent, optionally in the presence of a base and then performing a deprotection step to obtain the compound of formula (7)

which is finally reacted with a compound of formula (8), in the presence of an organic or inorganic base and optionally in the presence of a suitable copper salt or complex to yield a compound of formula (I-a)

wherein

R 3 and R 4 are hydrogen

R 5 is hydrogen,

L is methylene,

R 6 is phenyl,

wherein phenyl is substituted with 2 substituents independently selected from chloro, bromo and methyl,

R 7 is chloro, methyl, ethyl or ethenyl,

wherein methyl, ethyl and ethenyl are optionally substituted with one or two substituents independently selected from the group consisting of fluoro, chloro, hydroxy, methoxy and ethoxy,

R 8 is hydrogen,

Q is phenyl,

wherein phenyl is substituted with one or two substituents independently selected from fluoro, chloro, methyl, ethyl and cyclopropyl,

wherein cyclopropyl is optionally substituted with one or two substituents independently selected from the group consisting of fluoro and chloro.

Assignments (2)

Priority Claims (1)

Continuity (1)

References Cited (18)